{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:03:16Z","timestamp":1790287396959,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T00:00:00Z","timestamp":1543968000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Epidemiol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s10654-018-0468-7","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T21:03:02Z","timestamp":1543957382000},"page":"521-532","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["FranceCoag: a 22-year prospective follow-up of the national French cohort of patients with inherited bleeding disorders"],"prefix":"10.1007","volume":"34","author":[{"name":"for the FranceCoag Network","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Doncarli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2677-6259","authenticated-orcid":false,"given":"Virginie","family":"Demiguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Guseva Canu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Goulet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Bayart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Calvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Castet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Dalibard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohan","family":"Demay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Frotscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Goudemand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Lambert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Milien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Oudot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Sanni\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Chambost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,12,5]]},"reference":[{"issue":"1","key":"468_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1046\/j.1365-2516.2001.00457.x","volume":"7","author":"T Calvez","year":"2001","unstructured":"Calvez T, Biou M, Costagliola D, Jullien AM, Laurian Y, Rossi F, et al. The French haemophilia cohort: rationale and organization of a long-term national pharmacosurveillance system. Haemophilia. 2001;7(1):82\u20138.","journal-title":"Haemophilia"},{"issue":"3","key":"468_CR2","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1056\/NEJMoa1208024","volume":"368","author":"SC Gouw","year":"2013","unstructured":"Gouw SC, van der Bom JG, Ljung R, Escuriola C, Cid AR, Claeyssens-Donadel S, et al. Factor VIII products and inhibitor development in severe hemophilia A. N Engl J Med. 2013;368(3):231\u20139. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1208024\n                    \n                  .","journal-title":"N Engl J Med"},{"key":"468_CR3","volume-title":"Cohorte fran\u00e7aise des patients atteints de maladies h\u00e9morragiques par d\u00e9ficits h\u00e9r\u00e9ditaires en prot\u00e9ines de la coagulation. R\u00e9seau FranceCoag. Donn\u00e9es descriptives 2005. Enqu\u00eate","author":"J Donadieu","year":"2006","unstructured":"Donadieu J, Rothschild C, Laurian Y, Dieval J, Fressinaud E. Cohorte fran\u00e7aise des patients atteints de maladies h\u00e9morragiques par d\u00e9ficits h\u00e9r\u00e9ditaires en prot\u00e9ines de la coagulation. R\u00e9seau FranceCoag. Donn\u00e9es descriptives 2005. Enqu\u00eate. Saint-Maurice: Institut de Veille Sanitaire; 2006."},{"key":"468_CR4","first-page":"291","volume":"39","author":"A Doncarli","year":"2006","unstructured":"Doncarli A, Demiguel V, Ghez M, Doussin A, Gautier P, Faradji A, et al. Premier \u00e9tat des lieux du suivi de la population h\u00e9mophile en France (Cohorte FranceCoag), 1994\u20132005. Bull Epidemiol Hebd. 2006;39:291\u20134.","journal-title":"Bull Epidemiol Hebd"},{"issue":"6","key":"468_CR5","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S0929-693X(10)70026-9","volume":"17","author":"H Chambost","year":"2010","unstructured":"Chambost H, Suzan F, for FranceCoag Network g. Epidemiology of hereditary bleeding disorders: input of FranceCoag Network. Arch Pediatr. 2010;17(6):618\u20139. \n                    https:\/\/doi.org\/10.1016\/s0929-693x(10)70026-9\n                    \n                  .","journal-title":"Arch Pediatr"},{"key":"468_CR6","doi-asserted-by":"publisher","unstructured":"Goudemand J, Pouymayou K, Faradji A, Donadel-Claeyssens S, Rothschild C, Peynet J et al. FranceCoag Network is also the French registry of very rare coagulation bleeding disorders. Abstracts of the 29th International Congress of the World Federation of Hemophilia. Buenos Aires, Argentina. July 10\u201314, 2010. Haemophilia. 2010;16(Suppl 4):1\u2013158. \n                    https:\/\/doi.org\/10.1111\/j.1365-2516.2010.02283.x\n                    \n                  .","DOI":"10.1111\/j.1365-2516.2010.02283.x"},{"key":"468_CR7","doi-asserted-by":"publisher","unstructured":"Biron-Andr\u00e9ani C, Milien V, Gay V, Stieltjes N, Tintillier V, Falaise C. Rare bleeding disorders (RBD) in the FranceCoag Network: Diagnosis circumstances and severe events in patients with severe FVII deficiency. Abstracts of the 30th International Congress of the World Federation of Hemophilia. July 8-12, 2012. Paris, France. Haemophilia. 2012;18(Suppl 3):1\u2013226. \n                    https:\/\/doi.org\/10.1111\/j.1365-2516.2012.02820.x\n                    \n                  .","DOI":"10.1111\/j.1365-2516.2012.02820.x"},{"key":"468_CR8","doi-asserted-by":"publisher","unstructured":"Meunier S, Milien V, Pan Petesch B, Biernat J, Girault S, Cohen W et al. Rare bleeding disorders in the FranceCoag Network: Diagnosis circumstances and severe events in patients with severe FXIII deficiency under 10 per cent. Abstracts of the 30th International Congress of the World Federation of Hemophilia. July 8-12, 2012. Paris, France. Haemophilia. 2012;18(Suppl 3):1\u2013226. \n                    https:\/\/doi.org\/10.1111\/j.1365-2516.2012.02820.x\n                    \n                  .","DOI":"10.1111\/j.1365-2516.2012.02820.x"},{"key":"468_CR9","doi-asserted-by":"publisher","unstructured":"Volot F, Doncarli A, Bertrand MA, Guerin V, Roussel-Robert V, Pouymayou K et al. Rare bleeding disorders in the FranceCoag Network: Circumstances of diagnosis and clinical manifestations in the French population of patients with FXI deficiency under twenty per cent. Abstracts of the 30th International Congress of the World Federation of Hemophilia. July 8-12, 2012. Paris, France. Haemophilia. 2012;18(Suppl 3):1-226. \n                    https:\/\/doi.org\/10.1111\/j.1365-2516.2012.02820.x\n                    \n                  .","DOI":"10.1111\/j.1365-2516.2012.02820.x"},{"issue":"23","key":"468_CR10","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1182\/blood-2014-07-586347","volume":"124","author":"T Calvez","year":"2014","unstructured":"Calvez T, Chambost H, Claeyssens-Donadel S, d\u2019Oiron R, Goulet V, Guillet B, et al. Recombinant factor VIII products and inhibitor development in previously untreated boys with severe hemophilia A. Blood. 2014;124(23):3398\u2013408. \n                    https:\/\/doi.org\/10.1182\/blood-2014-07-586347\n                    \n                  .","journal-title":"Blood"},{"issue":"1","key":"468_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/j.1365-2516.2009.02127.x","volume":"16","author":"JS Stonebraker","year":"2010","unstructured":"Stonebraker JS, Bolton-Maggs PH, Soucie JM, Walker I, Brooker M. A study of variations in the reported haemophilia A prevalence around the world. Haemophilia. 2010;16(1):20\u201332. \n                    https:\/\/doi.org\/10.1111\/j.1365-2516.2009.02127.x\n                    \n                  .","journal-title":"Haemophilia"},{"issue":"23","key":"468_CR12","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1182\/blood-2014-07-580498","volume":"124","author":"PW Collins","year":"2014","unstructured":"Collins PW, Palmer BP, Chalmers EA, Hart DP, Liesner R, Rangarajan S, et al. Factor VIII brand and the incidence of factor VIII inhibitors in previously untreated UK children with severe hemophilia A, 2000-2011. Blood. 2014;124(23):3389\u201397. \n                    https:\/\/doi.org\/10.1182\/blood-2014-07-580498\n                    \n                  .","journal-title":"Blood"},{"key":"468_CR13","first-page":"51","volume":"136","author":"C Messiaen","year":"2008","unstructured":"Messiaen C, Le Mignot L, Rath A, Richard JB, Dufour E, Ben Said M, et al. CEMARA: a Web dynamic application within a N-tier architecture for rare diseases. Stud Health Technol Inform. 2008;136:51\u20136.","journal-title":"Stud Health Technol Inform"},{"issue":"4","key":"468_CR14","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1067\/mpd.2002.128115","volume":"141","author":"H Chambost","year":"2002","unstructured":"Chambost H, Gaboulaud V, Coatmelec B, Rafowicz A, Schneider P, Calvez T, et al. What factors influence the age at diagnosis of hemophilia? Results of the French hemophilia cohort. J Pediatr. 2002;141(4):548\u201352. \n                    https:\/\/doi.org\/10.1067\/mpd.2002.128115\n                    \n                  .","journal-title":"J Pediatr"},{"key":"468_CR15","doi-asserted-by":"publisher","unstructured":"Jousselme C, Demiguel V, Rafowicz A, Torchet MF, Wibaut B, Meunier S et al. Age at diagnosis of hemophilia: update from the French registry \u201cFranceCoag Network\u201d. Abstracts of the 29th International Congress of the World Federation of Hemophilia. Buenos Aires, Argentina. July 10-14, 2010. Haemophilia. 2010;16(Suppl 4):1\u2013158. \n                    https:\/\/doi.org\/10.1111\/j.1365-2516.2010.02283.x\n                    \n                  .","DOI":"10.1111\/j.1365-2516.2010.02283.x"},{"key":"468_CR16","unstructured":"R\u00e9seau FranceCoag. R\u00e9seau FranceCoag: la prise en charge des patients atteints d\u2019une maladie h\u00e9morragique h\u00e9r\u00e9ditaire. Le point en 2014. Institut de veille sanitaire, Saint-Maurice. 2015. \n                    https:\/\/www.francecoag.org\/SiteWebPublic\/pdfs\/Plaquette_03-2015.pdf\n                    \n                  ."},{"issue":"6","key":"468_CR17","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.jpeds.2012.11.080","volume":"162","author":"S Meunier","year":"2013","unstructured":"Meunier S, Chambost H, Demiguel V, Doncarli A, Suzan F, Trossaert M. Use of clinical practice guidelines on long-term prophylaxis in severe hemophilia in France: a retrospective audit. J Pediatr. 2013;162(6):1241\u20134. \n                    https:\/\/doi.org\/10.1016\/j.jpeds.2012.11.080\n                    \n                  .","journal-title":"J Pediatr"},{"issue":"1","key":"468_CR18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3324\/haematol.2017.174706","volume":"103","author":"T Calvez","year":"2018","unstructured":"Calvez T, Chambost H, d\u2019Oiron R, Dalibard V, Demiguel V, Doncarli A, et al. Analyses of the FranceCoag cohort support differences in immunogenicity among one plasma-derived and two recombinant factor VIII brands in boys with severe hemophilia A. Haematologica. 2018;103(1):179\u201389. \n                    https:\/\/doi.org\/10.3324\/haematol.2017.174706\n                    \n                  .","journal-title":"Haematologica"},{"issue":"2","key":"468_CR19","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1046\/j.1365-2141.2002.03293.x","volume":"116","author":"V Gaboulaud","year":"2002","unstructured":"Gaboulaud V, Parquet A, Tahiri C, Claeyssens S, Potard V, Faradji A, et al. Prevalence of IgG antibodies to human parvovirus B19 in haemophilia children treated with recombinant factor (F)VIII only or with at least one plasma-derived FVIII or FIX concentrate: results from the French haemophilia cohort. Br J Haematol. 2002;116(2):383\u20139.","journal-title":"Br J Haematol"}],"container-title":["European Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-018-0468-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10654-018-0468-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10654-018-0468-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,4]],"date-time":"2019-12-04T19:20:30Z","timestamp":1575487230000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10654-018-0468-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,5]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["468"],"URL":"https:\/\/doi.org\/10.1007\/s10654-018-0468-7","relation":{},"ISSN":["0393-2990","1573-7284"],"issn-type":[{"value":"0393-2990","type":"print"},{"value":"1573-7284","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,5]]},"assertion":[{"value":"29 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no potential conflicts of interest related to this description of the FranceCoag cohort.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}